184 related articles for article (PubMed ID: 27593858)
21. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma.
Zhang L; Liu H; Xie Y; Xia Y; Zhang B; Shan G; Li X
Eur J Surg Oncol; 2016 Jan; 42(1):81-6. PubMed ID: 26615455
[TBL] [Abstract][Full Text] [Related]
23. Preoperative subclinical hypothyroidism in patients with papillary thyroid carcinoma.
Ahn D; Sohn JH; Kim JH; Shin CM; Jeon JH; Park JY
Am J Otolaryngol; 2013; 34(4):312-9. PubMed ID: 23357595
[TBL] [Abstract][Full Text] [Related]
24. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
25. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.
Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS
Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961
[TBL] [Abstract][Full Text] [Related]
26. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
[TBL] [Abstract][Full Text] [Related]
27. Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes.
Kim SY; Kim BW; Pyo JY; Hong SW; Chang HS; Park CS
World J Surg; 2018 Jan; 42(1):123-129. PubMed ID: 28779384
[TBL] [Abstract][Full Text] [Related]
28. Accuracy of intraoperative determination of central node metastasis by the surgeon in papillary thyroid carcinoma.
Ji YB; Lee DW; Song CM; Kim KR; Park CW; Tae K
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):542-7. PubMed ID: 24429357
[TBL] [Abstract][Full Text] [Related]
29. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
[TBL] [Abstract][Full Text] [Related]
30. The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma.
Chen L; Zhu Y; Zheng K; Zhang H; Guo H; Zhang L; Wu K; Kong L; Ruan W; Hu J; Zhang X; Chen X
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1035-1042. PubMed ID: 28204971
[TBL] [Abstract][Full Text] [Related]
31. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
Yan B; Hou Y; Chen D; He J; Jiang Y
Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
[TBL] [Abstract][Full Text] [Related]
33. Incidental positive lymph nodes in patients with papillary thyroid cancer is independently associated with recurrent disease.
Kluijfhout WP; Drake FT; Pasternak JD; Beninato T; Vriens MR; Shen WT; Gosnell JE; Liu C; Suh I; Duh QY
J Surg Oncol; 2017 Sep; 116(3):275-280. PubMed ID: 28570769
[TBL] [Abstract][Full Text] [Related]
34. Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma.
Kim HI; Hyeon J; Park SY; Ahn HS; Kim K; Han JM; Bae JC; Shin JH; Kim JS; Kim SW; Chung JH; Kim TH; Oh YL
Thyroid; 2019 Jul; 29(7):963-970. PubMed ID: 31025609
[No Abstract] [Full Text] [Related]
35. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
36. Predictors of level II and Vb neck disease in metastatic papillary thyroid cancer.
Merdad M; Eskander A; Kroeker T; Freeman JL
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1030-3. PubMed ID: 23165376
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Metastatic Lymph Nodes on Risk Stratification in Differentiated Thyroid Cancer: Have We Reached a Higher Level of Understanding?
Urken ML; Haser GC; Likhterov I; Wenig BM
Thyroid; 2016 Apr; 26(4):481-8. PubMed ID: 26892765
[TBL] [Abstract][Full Text] [Related]
38. Extent of Extrathyroidal Extension as a Significant Predictor of Nodal Metastasis and Extranodal Extension in Patients with Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2017 Feb; 24(2):460-468. PubMed ID: 27654105
[TBL] [Abstract][Full Text] [Related]
39. Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients.
Suh YJ; Kwon H; Kim SJ; Choi JY; Lee KE; Park YJ; Park DJ; Youn YK
Ann Surg Oncol; 2015 Oct; 22(11):3543-9. PubMed ID: 25743326
[TBL] [Abstract][Full Text] [Related]
40. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
